P16 (CDKN2A) is a tumor suppressor gene that is hypermethylated at a prevalence of up to 67% in adenocarcinoma and 70% in squamous cell carcinoma of the lung [33]. Here, CDKN2A is linked to squamous cell lung carcinoma.